7876 Share Price Performance
NT$39.15
-4.05 (-9.38%)
Price NT$39.15
Share Pricen/a
Obigen Pharma Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
7876 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Obigen Pharma Inc. Key Details
About 7876
- Founded
- 2020
- Employees
- n/a
- CEO
- WebsiteView website
Obigen Pharma Inc. researches, develops, produces, manufactures, and sells botulinum toxin products in Taiwan. Its lead product OBI-858, a 760 kDa novel toxin protein which fermented and purified from clostridium botulinum type A bacteria, which is in Phase II clinical trial. The company was founded in 2020 and is based in Zhubei City, Taiwan.
